Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study.

World journal of gastroenterology(2023)

引用 0|浏览20
暂无评分
摘要
AZA administration is effective and safe, but it requires careful monitoring for potential minor and major side effects. Only 10% of patients who achieved remission with AZA needed a new treatment within 1 year of drug interruption.
更多
查看译文
关键词
inflammatory bowel diseases,withdrawal,mono-centric
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要